Detailed answers about IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED, including incorporation, status, business activity, and accounts information.
When was IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED founded?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED was officially incorporated on 6 June 1994 and is registered under company number 02935871. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED do?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED operates in the following sectors: 70229 - Management consultancy activities other than financial management, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED's registered address?
The registered office address of IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED is 4E THE LANTERNS, 16 MELBOURN STREET, ROYSTON, ENGLAND, SG8 7BX. This is the official address filed with Companies House for legal and statutory correspondence.
Is IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED financially stable?
The most recent accounts for IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED were made up to 31 December 2024, filed as UNAUDITED ABRIDGED. Next accounts are due by 30 September 2026.